The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies
Open accessAbstract
Over a century ago, Theodor Boveri paved the way to mechanistic studies linking chromosomal abnormalities to cancer pathogenesis. Since then, theoretical and empirical evidence has been accumulated, supporting a causal role of these events in the aetiology of human cancer. A powerful tool for measurement of chromosomal abnormalities is the cytokinesis-block micronucleus cytome (CBMNcyt) assay. The validation of the micronucleus (MN) as marker of phenotypic susceptibility to cancer has received decisive support from mutagens sensitivity studies, particularly from a recent case-control study on lung cancer, which showed increased frequency of tobacco carcinogen-induced MN, nuclear buds and especially nucleoplasmic bridges in cancer patients (odds ratios of 2.3, 10.0 and 45.5, respectively). Recently, a large international cohort study showed a significant association between MN frequency in healthy subjects and cancer risk. The study assembled data on 6718 individuals from 10 countries (62,980 person-years). Cancers incidence was significantly higher in groups with medium (RR=1.84; 95% confidence interval: 1.28-2.66) and high MN frequency (RR=1.53; 95% CI: 1.04-2.25). This study provided preliminary evidence that MN frequency in peripheral blood lymphocytes is predictive of cancer risk, suggesting that increased MN formation is associated with early events in carcinogenesis. These results, in combination with mechanistic evidence, prospected the use of MN frequency in cancer screening programmes. However, issues such as interindividual variability and preventive strategies in high-risk groups need to be further addressed to consolidate these achievements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Tobacco Smoke Carcinogens and Lung Cancer
Hecht, S. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.14.1194 · Cited by 1,976
The impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
Fenech, M., Kirsch-Volders, M., Natarajan, A. T., Surralles, J., Crott, J. W., Parry, J., Norppa, H., Eastmond, D. A., Tucker, J. D., & Thomas, P. (2011) · Mutagenesis · doi:10.1093/mutage/geq052 · Cited by 1,244
Self-citationBonassi, S., Znaor, A., Ceppi, M., Lando, C., Chang, W. P., Holland, N., Kirsch-Volders, M., Zeiger, E., Ban, S., Barale, R., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl177 · Cited by 1,023
Self-citationZur Frage der Entstehung maligner Tumoren
Boveri, T. (1914) · Cited by 801
The Less Harmful Cigarette: A Controversial Issue. A Tribute to Ernst L. Wynder
Hoffmann, D., Hoffmann, I., & El-Bayoumy, K. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000260u · Cited by 745
RESPONSE Re: Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
Berwick, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1537 · Cited by 545
Cigarette Smoking and Changes in the Histopathology of Lung Cancer
Thun, M. J., Lally, C. A., Calle, E. E., Heath, C. W., Flannery, J. T., & Flanders, W. D. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1580 · Cited by 500
Bonassi, S., Hagmar, L., Strömberg, U., Montagud, A. H., Tinnerberg, H., Forni, A., Heikkilä, P., Wanders, S., Wilhardt, P., Hansteen, I. L., et al. (2000) · PubMed · Cited by 493
Self-citationHagmar, L., Brögger, A., Hansteen, I. L., Heim, S., Högstedt, B., Knudsen, L. E., Lambert, B., Linnainmaa, K., Mitelman, F., & Nordenson, I. (1994) · PubMed · Cited by 485
Hagmar, L., Bonassi, S., Strömberg, U., Brögger, A., Knudsen, L. E., Norppa, H., & Reuterwall, C. (1998) · PubMed · Cited by 481
Self-citationHuman urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
Hecht, S. S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.907 · Cited by 404
Genetic susceptibility to breast cancer
Mavaddat, N., Antoniou, A. C., Easton, D. F., & Garcia-Closas, M. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.011 · Cited by 375
DNA adduct formation from tobacco-specific N-nitrosamines
Hecht, S. S. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00014-7 · Cited by 371
Fenech, M., & Bonassi, S. (2011) · Mutagenesis · doi:10.1093/mutage/geq050 · Cited by 371
Self-citationFusion genes and rearranged genes as a linear function of chromosome aberrations in cancer
Mitelman, F., Johansson, B., & Mertens, F. (2004) · Nature Genetics · doi:10.1038/ng1335 · Cited by 363
Genetic susceptibility to lung cancer: the role of DNA damage and repair.
Spitz, M. R., Wei, Q., Dong, Q., Amos, C. I., & Wu, X. (2003) · PubMed · Cited by 343
Bonassi, S., Norppa, H., Ceppi, M., Stromberg, U., Vermeulen, R., Znaor, A., Cebulska-Wasilewska, A., Fabianova, E., Fucic, A., Gundy, S., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn075 · Cited by 336
Self-citationFenech, M., & Crott, J. W. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00086-6 · Cited by 309
Self-citationBonassi, S., Abbondandolo, A., Camurri, L., Dal Prá, L., De Ferrari, M., Degrassi, F., Forni, A., Lamberti, L., Lando, C., Padovani, P., et al. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00131-t · Cited by 299
Self-citationChromosomal aberrations and SCEs as biomarkers of cancer risk
Norppa, H., Bonassi, S., Hansteen, I.-L., Hagmar, L., Strömberg, U., Rössner, P., Boffetta, P., Lindholm, C., Gundy, S., Lazutka, J., et al. (2006) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.05.030 · Cited by 293
Self-citationChromosomal biomarkers of genomic instability relevant to cancer
Fenech, M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02502-3 · Cited by 281
Self-citationThe relevance of tobacco-specific nitrosamines to human cancer.
Hecht, S. S., & Hoffmann, D. (1989) · PubMed · Cited by 231
Rothfuß, A., Schütz, P., Bochum, S., Volm, T., Eberhardt, E., Kreienberg, R., Vogel, W., & Speit, G. (2000) · PubMed · Cited by 228
Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk
Hagmar, L., Strömberg, U., Bonassi, S., Hansteen, I.-L., Knudsen, L. E., Lindholm, C., & Norppa, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3360 · Cited by 224
Self-citationCancers Exhibit a Mutator Phenotype: Clinical Implications
Loeb, L. A., Bielas, J. H., & Beckman, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5835 · Cited by 221
Abnormal Nuclear Shape in Solid Tumors Reflects Mitotic Instability
Gisselsson, D., Björk, J., Höglund, M., Mertens, F., Dal Cin, P., Åkerman, M., & Mandahl, N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63958-2 · Cited by 214
Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective
Bonassi, S., Znaor, A., Norppa, H., & Hagmar, L. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077519 · Cited by 200
Self-citationKaina, B., Ziouta, A., Ochs, K., & Coquerelle, T. (1997) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(97)00187-5 · Cited by 197
Roberts, S. A., Spreadborough, A. R., Bulman, B., Barber, J. B. P., Evans, D. G. R., & Scott, D. (1999) · The American Journal of Human Genetics · doi:10.1086/302544 · Cited by 197
Chromosomal Aberrations in Lymphocytes of Healthy Subjects and Risk of Cancer
Rossner, P., Boffetta, P., Ceppi, M., Bonassi, S., Smerhovsky, Z., Landa, K., Juzova, D., & Šrám, R. J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.6925 · Cited by 189
Self-citationChromosomal Aberrations and Cancer Risk: Results of a Cohort Study from Central Europe
Boffetta, P., van der Hel, O., Norppa, H., Fabianova, E., Fucic, A., Gundy, S., Lazutka, J., Cebulska-Wasilewska, A., Puskailerova, D., Znaor, A., et al. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj367 · Cited by 183
Self-citationMicronuclei frequency in peripheral blood lymphocytes of cancer patients: A meta-analysis
Iarmarcovai, G., Ceppi, M., Botta, A., Orsière, T. G., & Bonassi, S. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.05.006 · Cited by 152
Self-citationJin, Z., Gao, F., Flagg, T. O., & Deng, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404056200 · Cited by 138
Liou, S.-H., Lung, J. C., Chen, Y.-H., Yang, T.-Y., Hsieh, L., Chen, C., & Wu, T. (1999) · PubMed · Cited by 120
Kaina, B. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077469 · Cited by 114
Cytokinesis-Blocked Micronucleus Cytome Assay Biomarkers Identify Lung Cancer Cases Amongst Smokers
El‐Zein, R. A., Fenech, M. F., Lopez, M. S., Spitz, M. R., & Etzel, C. J. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2827 · Cited by 92
Self-citationAn inter-nordic prospective study on cytogenetic endpoints and cancer risk
Brögger, A., Hagmar, L., Hansteen, I., Heim, S., Högstedt, B., Knudsen, L. E., Lambert, B., Linnainmaa, K., Mitelman, F., Nordenson, I., et al. (1990) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(90)90071-h · Cited by 89
Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers
Baeyens, A., Thierens, H., Claes, K., Poppe, B. G., Ridder, L. D., & Vral, A. (2004) · International Journal of Radiation Biology · doi:10.1080/09553000400017937 · Cited by 79
Mutagen Sensitivity Has High Heritability: Evidence from a Twin Study
Wu, X., Spitz, M. R., Amos, C. I., Lin, J. M., Shao, L., Gu, J. H., de Andrade, M., Benowitz, N. L., Shields, P. G., & Swan, G. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1007 · Cited by 77
Jagetia, G. C., Jayakrishnan, A., Fernandes, D., et al. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(00)00132-7 · Cited by 74
Chromosomal radiosensitivity and low penetrance predisposition to cancer
Scott, D. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077517 · Cited by 73
Cloutier, J.-F., Drouin, R., Weinfeld, M., O'Connor, T. R., & Castonguay, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4997 · Cited by 69
Varga, D., Hoegel, J., Maier, C., Jainta, S., Hoehne, M., Patiño‐García, B., Michel, I., Schwarz-Boeger, U., Kiechle, M., Kreienberg, R., et al. (2006) · Mutagenesis · doi:10.1093/mutage/gel035 · Cited by 67
Elsendoorn, T. J., Weijl, N. I., Mithoe, S., et al. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00278-9 · Cited by 65
dos Santos, R. A., Teixeira, A. C., Mayorano, M. B., Carrara, H. H. A., de Andrade, J. M., & Takahashi, C. S. (2009) · Clinical and Experimental Medicine · doi:10.1007/s10238-009-0079-4 · Cited by 50
Mozdarani, H., MANSOURI, Z., & HAERI, S. A. (2005) · Journal of Radiation Research · doi:10.1269/jrr.46.111 · Cited by 50
Milošević-Djordjević, O., Grujičić, D., Vaskovic, Z., & Marinković, D. (2010) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.220.115 · Cited by 48
Trenz, K., Lugowski, S., Jahrsdörfer, U., Jainta, S., Vogel, W., & Speit, G. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.06.011 · Cited by 47
Słonina, D. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097142852 · Cited by 47
DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
Kotsopoulos, J., Chen, Z., Vallis, K. A., Poll, A., Ainsworth, P., & Narod, S. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603528 · Cited by 46
Critical steps in alkylation-induced aberration formation
Kaina, B. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00103-1 · Cited by 46
Molecular Epidemiology of Chronic Diseases
(2008) · Wiley eBooks · doi:10.1002/9780470725726 · Cited by 44
Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease.
Baeyens, A., den Broecke, R. V., Makar, A. P., Thierens, H., Ridder, L. D., & Vral, A. (2005) · PubMed · doi:10.3892/or.13.2.347 · Cited by 43
General lessons from large‐scale studies to identify human cancer predisposition genes
Cazier, J., & Tomlinson, I. P. M. (2009) · The Journal of Pathology · doi:10.1002/path.2650 · Cited by 40
Micronucleus analysis in patients with colorectal adenocarcinoma and colorectal polyps
Karaman, A., Binici, D. N., Kabalar, M. E., & Çalıkuşu, Z. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6835 · Cited by 37
Bolognesi, C., Filiberti, R., Neri, M., Perrone, E., Landini, E., Canessa, P. A., Simonassi, C., Cerrano, P. G., Mutti, L., & Puntoni, R. (2002) · PubMed · Cited by 36
Self-citationRossi, A. M., Hansteen, I., Skjelbred, C. F., Ballardin, M., Maggini, V., Murgia, E., Tomei, A., Viarengo, P., Knudsen, L. E., Barale, R., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11769 · Cited by 34
Self-citationCytogenetic biomarkers for human cancer
Keen‐Kim, D., Nooraie, F., & Rao, P. N. (2008) · Frontiers in bioscience · doi:10.2741/3127 · Cited by 32
Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk
Wu, X., Lin, J. M., Etzel, C. J., Dong, Q., Gorlova, O. Y., Zhang, Q. H., Amos, C. I., & Spitz, M. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22588 · Cited by 27
Cited by
Fenech, M., & Bonassi, S. (2011) · Mutagenesis · doi:10.1093/mutage/geq050 · Cited by 371
Self-citationImpact of obesity and overweight on DNA stability: Few facts and many hypotheses
Setayesh, T., Nersesyan, A., Mišík, M., Ferk, F., Langie, S., Andrade, V. M., Haslberger, A., & Knasmüller, S. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.07.001 · Cited by 98
Dimauro, I., Sgura, A., Pittaluga, M., Magi, F., Fantini, C., Mancinelli, R., Sgadari, A., Fulle, S., & Caporossi, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-04448-4 · Cited by 47
Font-Ribera, L., Marco, E., Grimalt, J. O., Pastor, S., Marcos, R., Abramsson-Zetterberg, L., Pedersen, M., Grummt, T., Junek, R., Barreiro, E., et al. (2019) · Environment International · doi:10.1016/j.envint.2019.104988 · Cited by 38
Metadata
- Authors
- Bonassi, S., El-Zein, R., Bolognesi, C., & Fenech, M.
- Venue
- Mutagenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-12-16
- Volume
- 26
- Issue
- 1
- Pages
- 93-100
- ISSN
- 0267-8357 (ISSN-L)
- 1464-3804
- OpenAlex
- W2149312363
- Cited by
- 471
- References
- 61
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.